Technology’s Role In Advancing Outcomes & Reducing The Cost Of Care For The SMI Population is starting in

Ohio v. Purdue Pharma, Teva Pharmaceuticals, Cephalon, Johnson & Johnson, Jannsen, Endo, Actavis, Watson Pharmaceuticals, et al.

On May 31, 2017, the Common Pleas Court of Ross County, Ohio issued this complaint by the State against multiple drug manufacturers and marketers of opioid pain relievers for misrepresenting the risks of opioids. The complaint names parent and subsidiary organizations of Purdue Pharma, Teva Pharmaceuticals, Cephalon, Johnson & Johnson, Jannsen, Endo, Actavis, and Watson Pharmaceuticals.

All defendants are accused of making false and deceptive statements in their marketing campaigns about the benefits of their various opioid medications and the risk of addiction, and of using a diverse group of seemingly independent third parties to spread misleading statements about the . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.